Supplementary Figure 11 shows that FOXO3 silencing rescues cell viability following ATF5 depletion</p
Supplementary Figure 16 shows that CP-d/n-ATF5 inhibits growth of BE(2)-C tumors and increases apopt...
Supplementary Figure 12 shows that CP-d/n-ATF5 inhibits the growth of MYCN-amplified and MYCN-non-am...
Supplementary Figure 15 shows that CP-d/n-ATF5 treatment does not induce BMF under adherent conditio...
Supplementary Figure 2 shows that ATF5 knockdown decreases neuroblastoma cell viability and promotes...
Supplementary Figure 3 shows the decreased expression of ATF5 in + Dox tumors</p
Supplementary Figure 7 shows that ATF5 knockdown decreases SK-N-DZ CTC survival</p
Supplementary Figure 13 shows that CP-d/n-ATF5 reduces the anchorage-independent viability of neurob...
Supplementary Figure 14 shows that CP-d/n-ATF5 induces anoikis of neuroblastoma cell lines</p
Supplementary Figure 1 shows that ATF5 is expressed in neuroblastoma cell lines.</p
Supplementary Figure 9 shows that BMF knockdown rescues ATF5 loss-induced reduction of anchorage-ind...
Supplementary Figure 18 shows that CP-d/n-ATF5 treatment decreased viability and induced anoikis of ...
Supplementary Figure 5 shows that overexpression of ATF5 promotes anoikis resistance of CHLA-255 in ...
Supplementary Figure 4 shows that decreased ATF5 expression does not alter the invasiveness of BE(2)...
Supplementary Figure 6 shows a decrease in ATF5 after Dox addition under non-adherent suspension con...
Supplementary Figure 17 shows that CP-dn-ATF5 reduces tumor growth and metastasis of SK-N-DZ in vivo...
Supplementary Figure 16 shows that CP-d/n-ATF5 inhibits growth of BE(2)-C tumors and increases apopt...
Supplementary Figure 12 shows that CP-d/n-ATF5 inhibits the growth of MYCN-amplified and MYCN-non-am...
Supplementary Figure 15 shows that CP-d/n-ATF5 treatment does not induce BMF under adherent conditio...
Supplementary Figure 2 shows that ATF5 knockdown decreases neuroblastoma cell viability and promotes...
Supplementary Figure 3 shows the decreased expression of ATF5 in + Dox tumors</p
Supplementary Figure 7 shows that ATF5 knockdown decreases SK-N-DZ CTC survival</p
Supplementary Figure 13 shows that CP-d/n-ATF5 reduces the anchorage-independent viability of neurob...
Supplementary Figure 14 shows that CP-d/n-ATF5 induces anoikis of neuroblastoma cell lines</p
Supplementary Figure 1 shows that ATF5 is expressed in neuroblastoma cell lines.</p
Supplementary Figure 9 shows that BMF knockdown rescues ATF5 loss-induced reduction of anchorage-ind...
Supplementary Figure 18 shows that CP-d/n-ATF5 treatment decreased viability and induced anoikis of ...
Supplementary Figure 5 shows that overexpression of ATF5 promotes anoikis resistance of CHLA-255 in ...
Supplementary Figure 4 shows that decreased ATF5 expression does not alter the invasiveness of BE(2)...
Supplementary Figure 6 shows a decrease in ATF5 after Dox addition under non-adherent suspension con...
Supplementary Figure 17 shows that CP-dn-ATF5 reduces tumor growth and metastasis of SK-N-DZ in vivo...
Supplementary Figure 16 shows that CP-d/n-ATF5 inhibits growth of BE(2)-C tumors and increases apopt...
Supplementary Figure 12 shows that CP-d/n-ATF5 inhibits the growth of MYCN-amplified and MYCN-non-am...
Supplementary Figure 15 shows that CP-d/n-ATF5 treatment does not induce BMF under adherent conditio...